22nd North American ISSX Meeting – Montréal, Canada (15th-19th July)
Dr Colin Brown will be presenting two posters at 22nd North American Meeting of the International Society for the Study of Xenobiotics.
Newcells Biotech Secures £2M Investment from NVM Private Equity and Northstar Ventures to Accelerate hiPSC Growth
Newcells Biotech has secured a £2 million investment from NVM Private Equity and Northstar Ventures to support its ambitious growth plans.
How the NHS Changed our world: Tyneside’s Genetic Pioneers on BBC 1 (North East and Cumbria)
As the NHS marks its 70th birthday, the BBC explores the genetic advances changing the face of medicine, including the extraordinary science that helped a blind man to see again.
Review Article – Cellular regeneration strategies for macular degeneration: past, present and future
Age-related macular degeneration (AMD) remains the commonest cause of blindness in the developed world. This review article by Dr Valeria Chichagova and Dr Dean Hallam provides an overview of progress made, ongoing studies and challenges ahead.
17th Annual World Preclinical Congress – Boston, MA (18th-21st June)
If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Colin Brown, then please let us know.
FMS Post-Doc Symposium 2018 – Newcastle University (15th June 2018)
Dr Valeria Chichagova will be presenting at the inaugural Faculty of Medical Science (FMS) Post-Doc Symposium on Friday 15th June 2018.
Dr Chichagova awarded best In Vitro Toxicology Society poster
This year’s British Toxicology Society Congress 2018 saw the IVTS Poster Prize awarded to our own Dr Valeria Chichagova, for her work in human retina models.
British Toxicological Society Annual Congress 2018 – Hilton Gateshead (16th-18th April)
The Newcells Biotech team will be attending the British Toxicological Society Annual Congress 2018 that is taking place in Gateshead on 16th-18th April.
Newcells Biotech to develop 3D retinal organoids using hiPSC derived skin cells
Newcells Biotech in partnership with Newcastle University has been awarded further funding from the NC3R CRACK IT project to create 3D retinal organoids that more closely recapitulate the structure and function of the human retina.
Current cell-based screens are poor models of human biology
Current cell assays for in vitro screening are based on genetically modified cell lines which are crude models of human biology.
hiPSCs derived cells in disease modelling
The discovery in 2007 that cells isolated from mature human tissues can be reprogrammed into cells that show pluripotency was a major breakthrough in stem cell science.
Renal drug handing and drug-drug interactions in ADMET
Led by Dr Colin Brown, Newcells Biotech has licensed-in an in vitro ADMET assay platform from Newcastle University to determine how new drugs are transported by the kidney.
